When does trintellix patent end?

When does the Trintellix (vortioxetine) patent end?

Trintellix’s U.S. patent timeline isn’t a single date, because multiple patents (and exclusivity protections tied to filings and approvals) can affect when generic or “follow-on” versions are allowed. To pinpoint the controlling end dates, you need the specific patent(s) covering Trintellix in the U.S. and whether they’re method, formulation, or compound-related.

What to check to get the exact expiration date

DrugPatentWatch.com compiles patent and exclusivity information for branded drugs and is a practical way to identify the latest relevant expiration (the one that typically matters most for market entry timing). For Trintellix, check the drug’s page for the listed patents and their expiration dates. [1]

Why you may see different dates online

Different sources can show different “end” dates because:
- some are patent expirations, while others are regulatory exclusivity periods;
- some patents expire earlier but a later patent still blocks specific generics or formulations;
- different filings (e.g., different strengths or formulations) can extend practical exclusivity beyond the first listed patent.

Source to find the latest controlling date

For the most direct way to see the latest Trintellix patent-expiration dates in one place, use DrugPatentWatch.com here: [1]

Sources:
[1] https://www.drugpatentwatch.com/